Triplex tetra-primer ARMS-PCR method for the simultaneous detection of MTHFR c.677C>T and c.1298A>C, and MTRR c.66A>G Polymorphisms of the folate-homocysteine metabolic pathway

Molecular and Cellular Probes

Volumn 26, Issue 1, 2012, Pages 16-20

  Lajin, Bassam ^a   Alachkar, Amal ^a   Alhaj Sakur, Amir ^a  

^a UNIVERSITY OF ALEPPO   (Syrian Arab Republic)

Author keywords

A1298C; A66G; C677T; Methionine synthase reductase (MTRR); Methylenetetrahydrofolate reductase (MTHFR); PCR CTPP; SNP; Tetra primer ARMS PCR

Indexed keywords

BETAINE; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

3' UNTRANSLATED REGION; ARTICLE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENOTYPE; HETEROZYGOSITY; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MELTING POINT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BETAINE; DNA PRIMERS; FERREDOXIN-NADP REDUCTASE; FOLIC ACID; GENE FREQUENCY; HOMOCYSTEINE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

TETRA;

EID: 84855999935     PISSN: 08908508     EISSN: 10961194     Source Type: Journal    
DOI: 10.1016/j.mcp.2011.10.005     Document Type: Article

References (43)

1. Shane B. Folate chemistry and metabolism. Folate in health and disease 1995, 1-22. Marcel Dekker, New York. L.B. Bailey (Ed.).
2. Wagner C. Biochemical role of folate in cellular metabolism. Folate in health and disease 1995, 23-42. Marcel Dekker, New York. L.B. Bailey (Ed.).
3. Kim Y.-I. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer?". Cancer Epidemiol Biomarkers Prev 2004, 13(4):511-519.
4. Bailey L.B., Rampersaud G.C., Kauwell G.P. Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: evolving science. JNutr 2003, 133(6):1961S-1968S.
5. Kim Y.I. Role of folate in colon cancer development and progression. JNutr 2003, 133(11 Suppl 1):3731S-3739S.
6. Veeranna V., Zalawadiya S.K., Niraj A., Pradhan J., Ference B., Burack R.C., et al. Homocysteine and reclassification of cardiovascular disease risk. JAm Coll Cardiol 2011, 58(10):1025-1033.
7. Mangoni A.A., Woodman R.J. Homocysteine and cardiovascular risk an old foe creeps back. JAm Coll Cardiol 2011, 58(10):1034-1035.
8. Ulrich C.M., Robien K., Sparks R. Pharmacogenetics and folate metabolism - a promising direction. Pharmacogenomics 2002, 3(3):299-313.
9. Fredriksen A., Meyer K., Ueland P.M., Vollset S.E., Grotmol T., Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum Mutat 2007, 28(9):856-865.
10. Koushik A., Kraft P., Fuchs C.S., Hankinson S.E., Willett W.C., Giovannucci E.L., et al. Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2006, 15(12):2408-2417.
11. Lissowska J., Gaudet M.M., Brinton L.A., Chanock S.J., Peplonska B., Welch R., et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer 2007, 120(12):2696-2703.
12. Moore L.E., Malats N., Rothman N., Real F.X., Kogevinas M., Karami S., et al. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 2007, 120(11):2452-2458.
13. Carr D.F., Whiteley G., Alfirevic A., Pirmohamed M. Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review. Pharmacogenomics J 2009, 9(5):291-305.
14. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. Acandidate genetic risk factor for vascular disease: a common mutation in ethylenetetrahydrofolate reductase. Nat Genet 1995, 10(1):111-113.
15. Weisberg I., Tran P., Christensen B., Sibani S., Rozen R. Asecond genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998, 64(3):169-172.
16. Bagley P.J., Selhub J. Acommon mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci 1998, 95(22):13217-13220.
17. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., et al. Asecond common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 1998, 62(5):1044-1051.
18. Skibola C.F., Forrest M.S., Coppede F., Agana L., Hubbard A., Smith M.T., et al. Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood 2004, 104(7):2155-2162.
19. Wiemels J.L., Smith R.N., Taylor G.M., Eden O.B., Alexander F.E., Greaves M.F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A 2001, 98(7):4004-4009.
20. Keku T., Millikan R., Worley K., Winkel S., Eaton A., Biscocho L., et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002, 11(12):1611-1621.
21. Weisberg I.S., Jacques P.F., Selhub J., Bostom A.G., Chen Z., Curtis Ellison R., et al. The 1298AC polymorphism in methylenetetrahydrofolate reductase (MTHFR): invitro expression and association with homocysteine. Atherosclerosis 2001, 156(2):409-415.
22. Gaughan D.J., Kluijtmans L.A., Barbaux S., McMaster D., Young I.S., Yarnell J.W., et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis 2001, 157(2):451-456.
23. Olteanu H., Munson T., Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002, 41(45):13378-13385.
24. Botto N., Andreassi M.G., Manfredi S., Masetti S., Cocci F., Colombo M.G., et al. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 2003, 11(9):671-678.
25. Alessio A.C., Annichino-Bizzacchi J.M., Bydlowski S.P., Eberlin M.N., Vellasco A.P., Hoehr N.F. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children. Am J Med Genet A 2004, 128A(3):256-260.
26. Marchal C., Redondo M., Reyes-Engel A., Perea-Milla E., Gaitan M.J., Machuca J., et al. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J Surg Oncol 2008, 34(7):805-810.
27. Szvetko A.L., Fowdar J., Nelson J., Colson N., Tajouri L., Csurhes P.A., et al. No association between MTHFR A1298C and MTRR A66G polymorphisms, and MS in an Australian cohort. JNeurol Sci 2007, 252(1):49-52.
28. Barbosa P.R., Stabler S.P., Machado A.L., Braga R.C., Hirata R.D., Hirata M.H., et al. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr 2008, 62(8):1010-1021.
29. Cai D., Ning L., Pan C., Liu X., Bu R., Chen X., et al. Association of polymorphisms in folate metabolic genes and prostate cancer risk: a case-control study in a Chinese population. JGenet 2010, 89(2):263-267.
30. Narayanan S., McConnell J., Little J., Sharp L., Piyathilake C.J., Powers H., et al. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes invivo. Cancer Epidemiol Biomarkers Prev 2004, 13(9):1436-1443.
31. Zhu H., Wicker N.J., Shaw G.M., Lammer E.J., Hendricks K., Suarez L., et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 2003, 78(3):216-221.
32. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., Tajima K. Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000, 91(9):865-868.
33. Ye S., Dhillon S., Ke X., Collins A.R., Day I.N. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001, 29(17):E88.
34. Masud R., Qureshi I.Z. Tetra primer ARMS-PCR relates folate/homocysteine pathway genes and ACE gene polymorphism with coronary artery disease. Mol Cell Biochem 2011, 355(1-2):289-297.
35. Breslauer K.J., Frank R., Blocker H., Marky L.A. Predicting DNA duplex stability from the base sequence. Proc Natl Acad U S A 1986.
36. Yoo J., Lee Y., Kim Y., Rha S.Y. SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis. BMC Bioinform 2008, 9:290.
37. Slatkin M., Excoffier L. Testing for linkage disequilibrium in genotypic data using the EM algorithm. Heredity 1996, 76:377-383.
38. Kawase H., Hamajima N., Tamakoshi A., Wakai K., Saito T., Tajima K. Triplex polymerase chain reactions with confronting two-pair primers (PCR-CTPP) for NQO1 C609T, GSTM1 and GSTT1 polymorphisms: a convenient genotyping method. Asian Pac J Cancer Prev 2003, 4(1):67-70.
39. Kawai S., Nishio K., Nakamura S., Sekido Y., Niwa T., Hamajima N. Multiplex PCR with confronting two-pair primers for CYP1A1 Ile462Val, GSTM1, GSTT1, and NQO1 C609T. Asian Pac J Cancer Prev 2005, 6(3):346-352.
40. Hamajima N., Saito T., Matsuo K., Tajima K. Competitive amplification and unspecific amplification in polymerase chain reaction with confronting two-pair primers. JMol Diagn 2002, 4(2):103-107.
41. Rees W.A., Yager T.D., Korte J., von Hippel P.H. Betaine can eliminate the base pair composition dependence of DNA melting. Biochemistry 1993, 32(1):137-144.
42. Shi M., Caprau D., Romitti P., Christensen K., Murray J.C. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol 2003, 67(8):545-549.
43. Rady P.L., Szucs S., Grady J., Hudnall S.D., Kellner L.H., Nitowsky H., et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002, 107(2):162-168.